S

Soleno Therapeutics
D

SLNO

64.120
USD
0.49
(0.77%)
مغلق
حجم التداول
19,496
الربح لكل سهم
-1
العائد الربحي
-
P/E
-15
حجم السوق
3,407,657,977
أصول ذات صلة الأخبار المقالات

العنوان: Soleno Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.